3,306
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Shotgun Metagenomics of Gastric Biopsies Reveals Compositional and Functional Microbiome Shifts in High- and Low-Gastric-Cancer-Risk Populations from Colombia, South America

, , , , , , & show all
Article: 2186677 | Received 30 Aug 2022, Accepted 27 Feb 2023, Published online: 12 Mar 2023

References

  • Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, Andersen L, Machado JC, Ianiro G, Gasbarrini A, et al. 2020. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 51(6):582–21. doi:10.1111/apt.15650.
  • Sheh A, Fox JG. 2013. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 4:505–531. doi:10.4161/gmic.26205.
  • Kwon SK, Park JC, Kim KH, Yoon J, Cho Y, Lee B, Lee JJ, Jeong H, Oh Y, Kim SH, et al. 2022. Human gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice. Gut. 71(7):1266–1276. doi:10.1136/gutjnl-2021-324489.
  • Bharti R, Grimm DG. 2021. Current challenges and best-practice protocols for microbiome analysis. Brief Bioinform. 22(1):178–193. doi:10.1093/bib/bbz155.
  • Wensel CR, Pluznick JL, Salzberg SL, Sears CL. 2022. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest. 132(7). doi:10.1172/JCI154944.
  • Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R. 2016. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One. 11(5):e0155362. doi:10.1371/journal.pone.0155362.
  • Jovel J, Patterson J, Wang W, Hotte N, O’Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong GK.2016. Characterization of the gut microbiome using 16S or Shotgun Metagenomics. Front Microbiol, 7:459. doi:10.3389/fmicb.2016.00459.
  • Mas-Lloret J, Obón-Santacana M, Ibáñez-Sanz G, Guinó E, Pato ML, Rodriguez-Moranta F, Mata A, García-Rodríguez A, Moreno V, Pimenoff VN. 2020. Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample. Sci Data. 7(1):92. doi:10.1038/s41597-020-0427-5.
  • Lloyd-Price J, et al. 2019. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 569(7758):655–662. doi:10.1038/s41586-019-1237-9.
  • Liu Y, et al. Exploring Gut Microbiota in Patients with Colorectal Disease Based on 16S rRNA Gene Amplicon and Shallow Metagenomic Sequencing. Front Mol Biosci, 2021;8:703638. doi:10.3389/fmolb.2021.703638.
  • Durazzi F, Sala C, Castellani G, Manfreda G, Remondini D, De Cesare A. 2021. Comparison between 16S rRNA and shotgun sequencing data for the taxonomic characterization of the gut microbiota. Sci Rep. 11(1):3030. doi:10.1038/s41598-021-82726-y.
  • Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13(9):R79. doi:10.1186/gb-2012-13-9-r79.
  • Yang I, et al. 2016. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep. 6(1):18594. doi:10.1038/srep18594.
  • Shen Z, et al. 2022. Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius isolated from humans have contrasting effects on H. pylori-Associated Gastric pathology and Host Immune Responses in a Murine model of Gastric cancer. mSphere. 7(1):e0077221. doi:10.1128/msphere.00772-21.
  • Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM, Camargo MC, Fox JG. 2021. Helicobacter pylori antimicrobial resistance andgene variants in High- and Low-Gastric-Cancer-Risk populations. J Clin Microbiol. 59(5). doi:10.1128/JCM.03203-20.
  • Gorkiewicz G, Moschen A. 2018. Gut microbiome: a new player in gastrointestinal disease. Virchows Arch. 472(1):159–172. doi:10.1007/s00428-017-2277-x.
  • Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. 2019. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 27(2):105–117. doi:10.1016/j.tim.2018.11.003.
  • Brooks JP, et al. 2015. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 15(1):66. doi:10.1186/s12866-015-0351-6.
  • Bruggeling CE, Garza DR, Achouiti S, Mes W, Dutilh BE, Boleij A. 2021. Optimized bacterial DNA isolation method for microbiome analysis of human tissues. Microbiologyopen. 10(3):e1191. doi:10.1002/mbo3.1191.
  • Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, Amani M, Fitzmaurice C, Nixon M, Abbasi N, et al. 2020. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 5(1):42–54. doi:10.1016/S2468-1253(19)30328-0.
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3):209–249. doi:10.3322/caac.21660.
  • Noto JM, Peek RMJ, Leong JM. 2017. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog. 13(10):e1006573. doi:10.1371/journal.ppat.1006573.
  • Osaki T, Mabe K, Hanawa T, Kamiya S. 2008. Urease-positive bacteria in the stomach induce a false-positive reaction in a urea breath test for diagnosis of Helicobacter pylori infection. J Med Microbiol. 57(7):814–819. doi:10.1099/jmm.0.47768-0.
  • Lee C-W,Rickman B, Rogers AB, Ge Z, Wang TC, Fox JG. 2008. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 68(9):3540–3548. doi:10.1158/0008-5472.CAN-07-6786.
  • Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, et al. 2011. Lack of Commensal Flora in Helicobacter pylori–infected INS-GAS mice reduces Gastritis and delays Intraepithelial Neoplasia. Gastroenterology. 140(1):210–220. doi:10.1053/j.gastro.2010.09.048.
  • Lee CW, Rickman B, Rogers AB, Muthupalani S, Takaishi S, Yang P, Wang TC, Fox JG. 2009. Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 69(20):8166–8174. doi:10.1158/0008-5472.CAN-08-3856.
  • Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, et al. 2012. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 104(6):488–492. doi:10.1093/jnci/djs003.
  • von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF. 2013. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. Isme J. 7(7):1354–1366. doi:10.1038/ismej.2013.33.
  • Freedberg DE, Lebwohl B, Abrams JA. 2014. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 34(4):771–785. doi:10.1016/j.cll.2014.08.008.
  • Alarcón T, Llorca L, Perez-Perez G. 2017. Impact of the Microbiota and Gastric disease development by Helicobacter pylori BT - Molecular Pathogenesis and signal Transduction by Helicobacter pylori. editorsTegtmeyer N Backert S. pp. 253–275. Springer International Publishing. 10.1007/978-3-319-50520-6_11.
  • Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, Iliev ID. 2022. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 185(20):3807–3822.e12. doi:10.1016/j.cell.2022.09.015.
  • Zhang Y, Shen J, Shi X, Du Y, Niu Y, Jin G, Wang Z, Lyu J. 2021. Gut microbiome analysis as a predictive marker for the gastric cancer patients. Appl Microbiol Biotechnol. 105(2):803–814. doi:10.1007/s00253-020-11043-7.
  • Liatsos C, Papaefthymiou A, Kyriakos N, Galanopoulos M, Doulberis M, Giakoumis M, Petridou E, Mavrogiannis C, Rokkas T, Kountouras J. 2022. Helicobacter pylori, gastric microbiota and gastric cancer relationship: unrolling the tangle. World J Gastrointest Oncol. 14(5):959–972. doi:10.4251/wjgo.v14.i5.959.
  • Dong Z, Chen B, Pan H, Wang D, Liu M, Yang Y, Zou M, Yang J, Xiao K, Zhao R, Zheng X, Zhang L, Zhang Y. 2019. Detection of microbial 16S rRNA Gene in the Serum of patients with gastric Cancer. Front Oncol. 9. doi:10.3389/fonc.2019.00608.
  • Liu X, Shao L, Liu X, Ji F, Mei Y, Cheng Y, Liu F, Yan C, Li L, Ling Z. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine, 2019;40:336–348. doi:10.1016/j.ebiom.2018.12.034.
  • Huang Y, Sun Y, Ma S, Chen L, Zhang H, Deng Y. 2013. Isolation and characterization of Keratinibaculum paraultunense gen. nov., sp. nov., a novel thermophilic, anaerobic bacterium with keratinolytic activity. FEMS Microbiol Lett. 345(1):56–63. doi:10.1111/1574-6968.12184.
  • Pappas-Gogos G, Tepelenis K, Fousekis F, Katsanos K, Pitiakoudis M, Vlachos K. 2022. The implication of Gastric Microbiome in the treatment of gastric cancer. Cancers (Basel). 14(8):2039. doi:10.3390/cancers14082039.
  • Hsieh YY, Tung SY, Pan HY, Yen CW, Xu HW, Lin YJ, Deng YF, Hsu WT, Wu CS, Li C. 2018. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep. 8(1):158. doi:10.1038/s41598-017-18596-0.
  • Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J. 2022. THe role of microbiota in gastrointestinal cancer and cancer treatment: chance or curse? Cell Mol Gastroenterol Hepatol. 13(3):857–874. doi:10.1016/j.jcmgh.2021.08.013.
  • Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C. 2018. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 67(2):226 LP–236. doi:10.1136/gutjnl-2017-314205.
  • Yang J, Zhou X, Liu X, Ling Z, Ji F. 2021;. Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol. 12. 10.3389/fmicb.2021.641322.
  • Kapsetaki SE, Marquez Alcaraz G, Maley CC, Whisner CM, Aktipis AD. 2022. Microbes, and cancer across the tree of life: a Systematic review. Curr Nutr Rep. 11(3):508–525. doi:10.1007/s13668-022-00420-5.
  • Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, Ge Z, Wang TC, Fox JG. 2014. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 63(1):54–63. doi:10.1136/gutjnl-2013-305178.
  • Bakhti SZ, Latifi-Navid S. 2021. Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next? BMC Microbiol. 21(1):71. doi:10.1186/s12866-021-02130-4.
  • Land M, Hauser L, Jun SR, Nookaew I, Leuze MR, Ahn TH, Karpinets T, Lund O, Kora G, Wassenaar T, Poudel S, Ussery DW. 2015. Insights from 20 years of bacterial genome sequencing. Funct Integr Genomics. 15(2):141–161. doi:10.1007/s10142-015-0433-4.
  • Clarridge JE. 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev. 3rd. 17(4): 840–862. table of contents. 10.1128/CMR.17.4.840-862.2004.
  • Mannion A, Shen Z, Fox JG. 2018. Comparative genomics analysis to differentiate metabolic and virulence gene potential in gastric versus enterohepatic Helicobacter species. BMC Genomics. 19:830. doi:10.1186/s12864-018-5171-2.
  • Krebes J, Morgan RD, Bunk B, Spröer C, Luong K, Parusel R, Anton BP, König C, Josenhans C, Overmann J, et al. 2014. The complex methylome of the human gastric pathogen Helicobacter pylori. Nucleic Acids Res. 42(4):2415–2432. doi:10.1093/nar/gkt1201.
  • Oleastro M, Ménard A. 2013. The role of Helicobacter pylori outer membrane proteins in adherence and Pathogenesis. Biology (Basel). 2:1110–1134. doi:10.3390/biology2031110.
  • Roesler BM, Rabelo-Gonçalves EMA, Zeitune JMR. 2014. Virulence factors of Helicobacter pylori: a review. Clin Med Insights Gastroenterol. 7:9–17. doi:10.4137/CGast.S13760.
  • Ailloud F, Didelot X, Woltemate S, Pfaffinger G, Overmann J, Bader RC, Schulz C, Malfertheiner P, Suerbaum S. 2019. Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps. Nat Commun. 10(1):2273. doi:10.1038/s41467-019-10050-1.
  • Cover TL. 2016. Helicobacter pylori diversity and Gastric cancer risk. MBio. 7(1):e01869. doi:10.1128/mBio.01869-15.
  • Hu Y-L, Pang W, Huang Y, Zhang Y, Zhang C-J. 2018;. The Gastric Microbiome is Perturbed in advanced Gastric Adenocarcinoma identified through Shotgun Metagenomics. Front Cell Infect Microbiol. 8. 10.3389/fcimb.2018.00433.
  • Maynard CL, Elson CO, Hatton RD, Weaver CT. 2012. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 489(7415):231–241. doi:10.1038/nature11551.
  • Thorell K, Bengtsson-Palme J, Liu OHF, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, et al. 2017. In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis. Infect Immun. 85(10). doi:10.1128/IAI.00031-17.
  • Sheh A, Artim SC, Burns MA, Molina-Mora JA, Lee MA, Dzink-Fox J, Muthupalani S, Fox JG. 2022. Analysis of gut microbiome profiles in common marmosets (Callithrix jacchus) in health and intestinal disease. Sci Rep. 12(1):4430. doi:10.1038/s41598-022-08255-4.
  • Lu J, Salzberg SL. 2020. Ultrafast and accurate 16S rRNA microbial community analysis using Kraken 2. Microbiome. 8(1):124. doi:10.1186/s40168-020-00900-2.
  • Wood DE, Lu J, Langmead B. 2019. Improved metagenomic analysis with Kraken 2. Genome Biol. 20(1):257. doi:10.1186/s13059-019-1891-0.
  • Lu J, Breitwieser FP, Thielen P, Salzberg SL. Bracken: estimating species abundance in metagenomics data. PeerJ Computer Science. 2017;3:e104 https://doi.org/10.7717/peerj-cs.104
  • Nurk S, Meleshko D, Korobeynikov A, Pevzner PA. 2017. metaSpades: a new versatile metagenomic assembler. Genome Res. 27(5):824–834. doi:10.1101/gr.213959.116.
  • Davis JJ, Wattam AR, Aziz RK, Brettin T, Butler R, Butler RM, Chlenski P, Conrad N, Dickerman A, Dietrich EM, et al. The PATRIC Bioinformatics Resource Center: expanding data and analysis capabilities. Nucleic Acids Res. 2020;48(D1):D606–D612. doi:10.1093/nar/gkz943.
  • Buchfink B, Xie C, Huson DH. 2015. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 12(1):59–60. doi:10.1038/nmeth.3176.
  • Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, McWilliam H, Maslen J, Mitchell A, Nuka G, et al. 2014. InterProScan 5: genome-scale protein function classification. Bioinformatics. 30(9):1236–1240. doi:10.1093/bioinformatics/btu031.
  • Moriya Y, Itoh M, Okuda S, Yoshizawa AC, Kanehisa M. 2007. KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res. 35(Web Server):W182–5. doi:10.1093/nar/gkm321.
  • Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. 2017. Microbiome datasets are compositional: anD this is not optional. Front Microbiol. 8:2224. doi:10.3389/fmicb.2017.02224.